Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV
Fig 2
Rates of viral decline to <200,000 IU/mL by select baseline characteristics.
Baseline Viral Load (A) ≥8 log10 IU/mL and (B) <8 log10 IU/mL, (C) HBeAg-positive and (D) HBeAg-negative patients. TAF, tenofovir alafenamide; TDF, tenofovir disoproxil fumarate.